Neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme-degraded polymannuronate on an in vitro Parkinson's disease-like model

This study mainly aimed to explore the intervention effect of an unsaturated mannuronate oligosaccharide (MOS) on Parkinson's disease (PD) and its potential mechanism at the cellular level. MOS, which possesses high water solubility and excellent biocompatibility, was prepared by enzyme degrada...

Full description

Saved in:
Bibliographic Details
Main Authors: Decheng Bi, Jinfeng Huang, Nanting Zhu, Jue Cao, Yan Wu, Lijun Yao, Xueying Ding, Jianyong Wu, Xu Cao, Xu Xu
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Journal of Agriculture and Food Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666154325003655
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849417801721184256
author Decheng Bi
Jinfeng Huang
Nanting Zhu
Jue Cao
Yan Wu
Lijun Yao
Xueying Ding
Jianyong Wu
Xu Cao
Xu Xu
author_facet Decheng Bi
Jinfeng Huang
Nanting Zhu
Jue Cao
Yan Wu
Lijun Yao
Xueying Ding
Jianyong Wu
Xu Cao
Xu Xu
author_sort Decheng Bi
collection DOAJ
description This study mainly aimed to explore the intervention effect of an unsaturated mannuronate oligosaccharide (MOS) on Parkinson's disease (PD) and its potential mechanism at the cellular level. MOS, which possesses high water solubility and excellent biocompatibility, was prepared by enzyme degradation of alginate-derived polymannuronate. In 6-hydroxydopamine (6-OHDA)-induced SH-SY5Y cell culture, MOS treatment effectively augmented the expression of tyrosine hydroxylase (TH), PTEN-induced putative kinase 1 (PINK1) and parkin but suppressed the expression of α-synuclein (α-syn). Moreover, MOS exerted antioxidant activity by suppressing the excessive generation of reactive oxygen species and enhancing the activity of superoxide dismutase. MOS also inhibited 6-OHDA-induced apoptosis by enhancing mitochondrial membrane potential and mitigating the Bax/Bcl-2 pathway and improving autophagy that was blocked by 6-OHDA. In summary, these results have demonstrated the significant neuroprotective effect of MOS on SH-SY5Y cells, indicating that MOS has a certain intervention effect on the development of PD. This provides a promising foundation for developing novel therapeutic strategies targeting neurodegenerative disorders.
format Article
id doaj-art-cd6d0c76458a45f497498a2428ea3bf3
institution Kabale University
issn 2666-1543
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series Journal of Agriculture and Food Research
spelling doaj-art-cd6d0c76458a45f497498a2428ea3bf32025-08-20T03:32:37ZengElsevierJournal of Agriculture and Food Research2666-15432025-08-012210199410.1016/j.jafr.2025.101994Neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme-degraded polymannuronate on an in vitro Parkinson's disease-like modelDecheng Bi0Jinfeng Huang1Nanting Zhu2Jue Cao3Yan Wu4Lijun Yao5Xueying Ding6Jianyong Wu7Xu Cao8Xu Xu9Shenzhen Key Laboratory of Marine Bioresources and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, PR ChinaShenzhen Key Laboratory of Marine Bioresources and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, PR China; Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, PR ChinaShenzhen Key Laboratory of Marine Bioresources and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, PR ChinaShenzhen Key Laboratory of Marine Bioresources and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, PR China; Key Laboratory Marine Biological Waste and Comprehensive Utilization of Guangdong Province, Zhanjiang, 524051, PR ChinaInstrumental Analysis Center, Shenzhen University, Shenzhen, 518060, PR ChinaShenzhen Key Laboratory of Marine Bioresources and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, PR ChinaDepartment of Neurology, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen, 518055, PR ChinaDepartment of Food Science and Nutrition, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong KongDepartment of Neurology, Shenzhen University General Hospital, Shenzhen University Clinical Medical Academy, Shenzhen, 518055, PR China; Corresponding author.Shenzhen Key Laboratory of Marine Bioresources and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, PR China; Corresponding author.This study mainly aimed to explore the intervention effect of an unsaturated mannuronate oligosaccharide (MOS) on Parkinson's disease (PD) and its potential mechanism at the cellular level. MOS, which possesses high water solubility and excellent biocompatibility, was prepared by enzyme degradation of alginate-derived polymannuronate. In 6-hydroxydopamine (6-OHDA)-induced SH-SY5Y cell culture, MOS treatment effectively augmented the expression of tyrosine hydroxylase (TH), PTEN-induced putative kinase 1 (PINK1) and parkin but suppressed the expression of α-synuclein (α-syn). Moreover, MOS exerted antioxidant activity by suppressing the excessive generation of reactive oxygen species and enhancing the activity of superoxide dismutase. MOS also inhibited 6-OHDA-induced apoptosis by enhancing mitochondrial membrane potential and mitigating the Bax/Bcl-2 pathway and improving autophagy that was blocked by 6-OHDA. In summary, these results have demonstrated the significant neuroprotective effect of MOS on SH-SY5Y cells, indicating that MOS has a certain intervention effect on the development of PD. This provides a promising foundation for developing novel therapeutic strategies targeting neurodegenerative disorders.http://www.sciencedirect.com/science/article/pii/S2666154325003655Unsaturated mannuronate oligosaccharide (MOS)Parkinson's disease (PD)Cell culture modelAntioxidantAnti-apoptosisAutophagy
spellingShingle Decheng Bi
Jinfeng Huang
Nanting Zhu
Jue Cao
Yan Wu
Lijun Yao
Xueying Ding
Jianyong Wu
Xu Cao
Xu Xu
Neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme-degraded polymannuronate on an in vitro Parkinson's disease-like model
Journal of Agriculture and Food Research
Unsaturated mannuronate oligosaccharide (MOS)
Parkinson's disease (PD)
Cell culture model
Antioxidant
Anti-apoptosis
Autophagy
title Neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme-degraded polymannuronate on an in vitro Parkinson's disease-like model
title_full Neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme-degraded polymannuronate on an in vitro Parkinson's disease-like model
title_fullStr Neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme-degraded polymannuronate on an in vitro Parkinson's disease-like model
title_full_unstemmed Neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme-degraded polymannuronate on an in vitro Parkinson's disease-like model
title_short Neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme-degraded polymannuronate on an in vitro Parkinson's disease-like model
title_sort neuroprotective effect of an unsaturated mannuronate oligosaccharide derived from enzyme degraded polymannuronate on an in vitro parkinson s disease like model
topic Unsaturated mannuronate oligosaccharide (MOS)
Parkinson's disease (PD)
Cell culture model
Antioxidant
Anti-apoptosis
Autophagy
url http://www.sciencedirect.com/science/article/pii/S2666154325003655
work_keys_str_mv AT dechengbi neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT jinfenghuang neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT nantingzhu neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT juecao neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT yanwu neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT lijunyao neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT xueyingding neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT jianyongwu neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT xucao neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel
AT xuxu neuroprotectiveeffectofanunsaturatedmannuronateoligosaccharidederivedfromenzymedegradedpolymannuronateonaninvitroparkinsonsdiseaselikemodel